Greater Cannabis Co. Reports Equity Sales & Officer Changes
Ticker: GCAN · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1695473
| Field | Detail |
|---|---|
| Company | Greater Cannabis Company, Inc. (GCAN) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, management-change, filing
TL;DR
Greater Cannabis Co. sold unregistered equity and changed some execs/directors. Watch for dilution.
AI Summary
The Greater Cannabis Company, Inc. filed an 8-K on April 10, 2025, reporting on events as of April 3, 2025. The filing covers unregistered sales of equity securities and changes in directors and officers, including compensatory arrangements. Specific details on the equity sales or the individuals involved in the board changes were not provided in this excerpt.
Why It Matters
This filing indicates potential dilution from new equity sales and changes in the company's leadership, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Unregistered equity sales can lead to dilution, and changes in leadership introduce uncertainty.
Key Numbers
- 20250403 — Date of earliest event (Reporting period for the 8-K filing)
- 20250410 — Filing date (Date the 8-K was submitted to the SEC)
Key Players & Entities
- Greater Cannabis Company, Inc. (company) — Registrant
- Florida (jurisdiction) — State of incorporation
- 15 Walker Ave, Suite 101 Baltimore, MD 21208 (address) — Principal Executive Offices
FAQ
What type of equity securities were sold?
The filing mentions 'Unregistered Sales of Equity Securities' but does not specify the type of securities in the provided excerpt.
Were there any new appointments to the board or as officers?
The filing indicates 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item reported, suggesting changes occurred.
What are the details of the compensatory arrangements for officers?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details are not included in this excerpt.
What is the company's primary business?
The Standard Industrial Classification (SIC) code is 'PHARMACEUTICAL PREPARATIONS [2834]', suggesting a focus on pharmaceuticals.
When is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Greater Cannabis Company, Inc. (GCAN).